3LBA Initial report of a first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640 by Infante, J, Patel, M, von Hoff, D, Brenner, A, Rubino, C, McCulloch, W, Zhukova-Harrill, V, Parsey, M

Get full text

27LBA Evidence of activity of a new mechanism of action (MoA): A first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor, TVB-2640, as monotherapy or in com... by Arkenau, H.T, Voskoboynik, M, Infante, J, Brenner, A, Patel, M, Borazanci, E, Falchook, G, Molife, L.R, Pant, S, Dean, E, Pelosof, L, Jones, S, Rubino, C, McCulloch, W, Zhukova-Harrill, V, Kemble, G, O'Farrell, M, Burris, H

Get full text